FICS
FINAL DISPOSITION NOTICE SENT TO IB
16/07/2026
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Snapshot rápido
ST13
US500000079412458Classe
Pedido
Registro
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Código do desenho
Tipo de titular
Localização do titular
Examinador
Unidade examinadora
Localização atual
Descrição da marca
The mark consists of a motion mark beginning with an animated representation of the white letters "T H R P T X" moving towards the center of a black background from all external directions and gathering to form six rows showing THRPTX in each horizonal row. After the rows form, the letters T H R P T X are highlighted in a diagonal pattern descending from top left to bottom right. The letters fade away and the diagonal display rotates to show the final horizontal display of "THRPTX" in white letters on a black background.
Titulares
Representantes
Maury M. Tepper, III Tepper & Eyster, PLLC
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Downloadable or recorded software for diagnosis, surveillance, prevention and treatment in the fields of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; software recorded on magnetic media or downloaded from a remote computer network for diagnosis, surveillance, prevention and treatment in the fields of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; downloadable computer software applications for diagnosis, surveillance, prevention and treatment in the fields of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; downloadable applications for mobile devices for diagnosis, surveillance, prevention and treatment in the fields of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders
Classe 16
Printed instructional or teaching material in the field of pharmaceuticals, pharmaceutical research and disease management; printed magazines in the field of pharmaceuticals, pharmaceutical research and disease management; printed periodicals in the field of pharmaceuticals, pharmaceutical research and disease management; printed pamphlets in the field of pharmaceuticals, pharmaceutical research and disease management
Classe 38
Broadcasting of podcasts; transmission of podcasts; broadcasting of radio programs; broadcasting and transmission of radio programs; audio broadcasting; video broadcasting; digital audio broadcasting; radio broadcasting; dissemination being transmission of audiovisual and multimedia content via the Internet
Classe 41
Training services in the field of pharmaceuticals, pharmaceutical research and disease management; organization and conducting of events, colloquiums, conferences, congresses, seminars or symposiums in the field of pharmaceuticals, pharmaceutical research and disease management; preparation and conducting of educational conferences and events in the field of pharmaceuticals, pharmaceutical research and disease management; organization of seminars and conferences in the field of pharmaceuticals, pharmaceutical research and disease management; multimedia publishing; podcast production
Classe 42
Development of computer equipment and software; updating of software; programming for computers; electronic data storage; hosting of web portals; temporary provision of non-downloadable software applications accessible via a website in the field of pharmaceuticals, pharmaceutical research and disease management; internet web site design services; software development
Classe 44
Providing advice with respect to health; information services relating to health
Histórico de despachos e eventos da marca no USPTO.
28 publicações encontradas
FINAL DISPOSITION NOTICE SENT TO IB
16/07/2026
FINAL DISPOSITION PROCESSED
16/07/2026
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
04/06/2026
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
18/05/2026
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
18/05/2026
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/04/2026
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/01/2026
REGISTERED-PRINCIPAL REGISTER
06/01/2026
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
18/11/2025
PUBLISHED FOR OPPOSITION
18/11/2025
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/11/2025
APPROVED FOR PUB - PRINCIPAL REGISTER
20/10/2025
PREVIOUS ALLOWANCE COUNT WITHDRAWN
20/10/2025
TEAS/EMAIL CORRESPONDENCE ENTERED
16/09/2025
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/09/2025
TEAS RESPONSE TO OFFICE ACTION RECEIVED
16/09/2025
REFUSAL PROCESSED BY IB
12/07/2025
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
23/06/2025
REFUSAL PROCESSED BY MPU
23/06/2025
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
25/04/2025
NON-FINAL ACTION WRITTEN
24/04/2025
ASSIGNED TO EXAMINER
08/04/2025
ASSIGNED TO EXAMINER
20/03/2025
ASSIGNED TO EXAMINER
19/03/2025
ASSIGNED TO EXAMINER
18/03/2025
APPLICATION FILING RECEIPT MAILED
27/12/2024
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
27/12/2024
SN ASSIGNED FOR SECT 66A APPL FROM IB
19/12/2024
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.